Security key
71678J209
Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (PTPI)
CUSIP: 71678J209
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value
- Total 13F shares
- 1,130,141
- Total 13F value
- $77,574
- Share change
- +1,032,453
- SEC-reported price per share
- $0.07
- Number of holders
- 15
- Value change
- +$70,830
- Number of buys
- 10
- Shares outstanding
- 25,296,136
Holder snapshot
5 signals
Security identity
1 source field
Report period
Q1 2025
Institutions
15
Top holders
10
PTPI full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Petros Pharmaceuticals, Inc. SEC filings
Petros Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 71678J209
Recent filing periods:
Ownership snapshot
Top reported holders of PTPI - Petros Pharmaceuticals, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Iroquois Capital Manageme...
Disclosed value leader
John D. Shulman
Comparable rows
11/15
Latest evidence
31 Mar 2025
13D/G
13F
3/4/5
Lead comparable stake: 10%
4 rows are not safely comparable across share classes.
13D/G row: Iroquois Capital Management, LLC
Showing 1-6 of 15 holder rows.
Quick read
Iroquois Capital Management, LLC leads the comparable SEC ownership view at 10%.
11 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
Iroquois Capital Management, LLC
10%
Ayrton Capital LLC
6.2%
GEODE CAPITAL MANAGEMENT, LLC
0.14%
VANGUARD GROUP INC
0.13%
BlackRock, Inc.
0.06%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Iroquois Capital Management, LLC |
13D/G
|
10%
|
$59,400
5,939,954 shares
|
+$34,129 | 31 Mar 2025 |
| Ayrton Capital LLC |
13D/G
|
6.2%
|
$6,576
657,614 shares
|
$0 | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.14%
|
$14,252
36,184 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.13%
|
$12,534
31,811 shares
|
— | 31 Dec 2024 |
| BlackRock, Inc. |
13F
Company
|
0.06%
|
$6,353
16,128 shares
|
— | 31 Dec 2024 |
| UBS Group AG |
13F
Company
|
0.05%
|
$5,119
12,992 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
1,130,141
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
9
Q1 2025 holders
15
Holder diff
6
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend